STAT

STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments

STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatmentsWorldPing

The FDA approved a novel type of treatment for narcolepsy made by Takeda, backing a new drug class that scientists hope can be used to treat other conditions.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news